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Nanogram amounts of the proinflammatory cytokine interleukin-1a (IL-1a) were detected in uninfected cultures of human
corneal epithelial cells (HCEC). Although HSV-1 replicated .104-fold in these cells and caused extensive cytopathic effects,
virus infection was not accompanied by significant extracellular release of IL-1a. Additional studies showed that release of
radiolabeled cytosolic proteins from virus-infected HCEC was no greater than that released by mock-infected cells. These
findings indicate that HSV-1 infection of HCEC does not result in IL-1a release because newly formed virus progeny can
escape infected cells without disrupting cell membranes. © 1998 Academic Press
INTRODUCTION
Interleukin 1a (IL-1a) is a cytokine produced in re-
sponse to infection and is involved in regulation of acute
inflammation and specific immune responses as well as
in the activation of secondary cytokines involved in host
defenses (Dinarello, 1994a,b). Epithelial cells found at
many epidermal surfaces can initiate inflammatory reac-
tions in response to disease or injury through their ca-
pacity to synthesize this proinflammatory mediator con-
stitutively (Gahring et al., 1985; Hauser et al., 1986; Ka-
meda and Sato, 1994; Kupper et al., 1986; Sauder et al.,
1982). Even though epithelial cells synthesize IL-1a, they
do not secrete the cytokine by the classical secretory
pathway but store the molecule in the cytoplasm in a
biologically active form until it is passively released
when cellular membranes are disrupted by disease or
injury (Bakouche et al., 1987; Matushima et al., 1986;
Stevenson et al., 1992). Once IL-1a escapes the cell, it
initiates local inflammatory responses by upregulating
the synthesis of chemokines, which then induce extra-
vasation of inflammatory cells from blood vessels and
chemoattract them into sites of tissue injury (Dustin et
al., 1986; Furie and Randolph, 1995; Groves et al., 1992;
Strieter et al., 1996; Waltz et al., 1990).
The corneal surface is composed of a layer of trans-
parent epithelial cells resting upon a stratum of connec-
tive tissue called the stroma. Ocular herpes is a disease
initiated by infection of the epithelial and stromal layers
of the eye surface with HSV-1, resulting in the infiltration
of lymphocytes, neutrophils, and monocytes into the stro-
mal layer of the cornea. Although these white blood cells
are important in providing protection against the patho-
gen, their biological activities can also damage corneal
tissues, leading to scar formation and vision loss (Hen-
dricks and Tumpey, 1990; Metcalf and Kaufman, 1976;
Meyers and Pettit, 1974; Meyers-Elliot and Chitjian, 1981;
Pepose, 1991; Thomas et al., 1997). The precise mecha-
nisms whereby inflammation is initiated within HSV-1-
infected corneas is not known. Many pathogens initiate
inflammation by inducing release of preformed cytoplas-
mic IL-1a from epithelial cells (Agace et al., 1993; Eck-
mann et al., 1995; Rasmussen et al., 1997; Walters et al.,
1995). Since HSV-1 replication kills infected cells (Roiz-
man and Sears, 1996), it is reasonable to propose that
inflammatory processes which develop during ocular
herpes are also initiated in part by release of IL-1a from
damaged corneal epithelial cells. This study was initi-
ated to test the hypothesis that HSV-1 infection results in
IL-1a release from human corneal epithelial cells. To our
surprise, we found that the virus growth cycle goes to
completion without inducing significant release of pre-
formed intracellular IL-1a.
RESULTS
The effects of HSV-1 infection upon human corneal
epithelial cells
Epithelial cell monolayers infected with HSV-1 demon-
strated extensive cytopathic effects by 24 h postinfection.
By 36 h postinfection, .90% of the cells had detached
from the flask to become suspended in the culture me-
dium. At this time, it was found that the number of both
extracellular and intracellular plaque forming units had
increased by greater than four logs (Fig. 1). The number
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of cells killed during the virus growth cycle was deter-
mined by trypan blue exclusion (Strober et al., 1997). It
was found that by 36 h postinfection, .70% of the cells in
the infected cell monolayers were not viable (Fig. 2).
These results demonstrated that HSV-1 replicates in
HCEC and that the production of viral progeny results in
the death of infected cells.
The effects of HSV-1 infection upon intracellular IL-1a
stores
We next determined the quantities of IL-1a stored in
HCEC and whether IL-1a is released during the virus
growth cycle. It was found that HCEC incubated in
growth medium synthesize .1 ng/106 cells of intracellu-
lar IL-1a (Fig. 3). However, during 36 h of incubation
,4.0% of the IL-1a was released into the culture medium
(Fig. 3). In order to determine if significant quantities of
IL-1a are released following damage to cytoplasmic
membranes, cells were rinsed three times with phos-
phate-buffered saline (PBS) and then exposed to 80
mg/ml digitonin for 10 min at room temperature. Digitonin
is a non-ionic detergent which permeabilizes plasma
membranes, releasing cytoplasmic proteins (Adam et al.,
1990; Cserpa´n and Udvardy, 1995). When supernatants
collected from digitonin-treated cells were assayed for
IL-1a, they were found to contain .1 ng of the cytokine/
106 cells (Fig. 4). Thus, permeabilized HCEC release
nearly all of their intracellular IL-1a. In contrast to digi-
tonin treatment, however, infection of epithelial cells with
HSV-1 did not significantly increase the amounts of IL-1a
released even when they were infected at a m.o.i. of 10
(P , 0.01) (Fig. 4). Intracellular stores of IL-1a were not
destroyed during the virus growth cycle because in-
fected cells possessed .1 ng of IL-1a/106 cells at 48 and
72 h postinfection (Fig. 5). This is close to the amount of
intracellular IL-1a found to be associated with nonin-
fected cells in earlier experiments (Fig. 3).
FIG. 1. Growth of HSV-1 in cultured human corneal epithelial cells.
Confluent cultures of human corneal epithelial cells were infected with
HSV-1 at a m.o.i. of 3. At selected times postinfection, supernatants
were removed and the cells were scraped from the flasks and soni-
cated to release infectious virus. Supernatants and cellular lysates
were assayed for infectious virus particles on cultured human corneal
fibroblast cells. The values shown represent means 6 SEM of identical
experiments performed in cultures established from three corneal
donors.
FIG. 2. Survival of HSV-1 (RE)-infected human corneal epithelial cells.
Monolayers of epithelial cells were either mock-infected or infected
with HSV-1 (RE). At selected times postinfection, the viability of the cells
was estimated by the trypan blue exclusion assay. The values shown
represent means 6 SEM of identical experiments in cultures estab-
lished from three corneal donors.
FIG. 3. Constitutive IL-1a production in cultures of human corneal
epithelial cells. Confluent cultures of human corneal epithelial cells
were grown in 25-cm2 flasks. Following the addition of fresh medium,
extracellular IL-1a was collected by removing the medium from indi-
vidual flasks at regular intervals. The cells were then harvested and
intracellular IL-1a was released by sonication. Supernatants and cell
lysates were assayed for IL-1a by ELISA. The values shown represent
means 6 SEM of identical experiments performed in cultures estab-
lished from three corneal donors.
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The effects of HSV-1 infection upon cell permeability
The failure of HSV-1 infection to cause significant
release of IL-1a may be due to the fact that infected
corneal epithelial cell membranes are not sufficiently
damaged to allow IL-1a to escape. To test this hypothe-
sis, we determined whether the amount of soluble pro-
teins released from HCEC is enhanced by virus infection.
Uninfected HCEC were found to release approximately
30% of their proteins into the growth medium during 48 h
of incubation (Fig. 6). In order to determine the quantities
of soluble cytosolic protein retained in epithelial cells,
we treated cells at selected times postlabeling with dig-
itonin. Exposure of epithelial cells to this detergent en-
hanced the amount of protein released from epithelial
cells by .40% (Fig. 6). Extension of the incubation time or
use of higher digitonin concentrations did not signifi-
cantly increase the amount of 35S-labeled protein re-
leased (data not shown). When monolayers of epithelial
cells were infected with HSV-1, the amount of intracellu-
lar proteins released was not significantly enhanced
over uninfected cells even after infection at a m.o.i. of 10
(Fig. 6). These results suggest that HSV-1-infected hu-
man corneal epithelial cells (HCEC) are not lysed during
the virus growth cycle.
DISCUSSION
Our results provide evidence that HSV-1 can complete
its growth cycle in human corneal epithelial cells without
inducing significant release of preformed IL-1a stored
within the cell. Since infected cultures produce .104
PFU/ml of infectious extracellular virus particles 36 h
after infection, it appears that significant numbers of
newly formed progeny can exit cells without damaging
the permeability barrier of cell membranes. HSV-1 repli-
cation is generally thought to be lytic for many types of
FIG. 4. Effect of HSV-1 infection on IL-1a release from human corneal
epithelial cells. Confluent cultures of epithelial cells were either mock-
infected or infected with HSV-1. At selected times postinfection, extra-
cellular IL-1a was collected by removing the medium from individual
flasks. Cytoplasmic IL-1a was released from uninfected cells by per-
meabilization of cell membranes with 80 mg/ml digitonin for 10 min at
room temperature. Extracellular medium and cell lysates were assayed
for IL-1a by ELISA. The values shown represent means 6 SEM of
identical experiments performed in cultures established from four cor-
neal donors.
FIG. 5. Levels of intracellular IL-1a in HSV-1-infected human corneal
epithelial cells. Confluent cultures of human corneal epithelial cells
were infected with HSV-1. At selected times postinfection, intracellular
IL-1a was collected by trypsinizing and sonicating the cells to release
their intracellular contents. Sonicated samples were assayed for IL-1a
by ELISA. The values shown represent means 6 SEM of identical
experiments performed in cultures established from three corneal
donors.
FIG. 6. The effect of HSV-1 infection upon cell permeability. Confluent
cultures of human corneal epithelial cells in 24-well plates were la-
beled for 3 h before infection with translabel (25 mCi/ml sp act). The
cells were washed 23 with PBS and then either infected with HSV-1 or
mock-infected. At selected times postinfection, medium was collected
from flasks for analysis of extracellular radiolabeled proteins. Any
detached cells were removed by centrifugation prior to analyzing re-
leased proteins. Uninfected cell monolayers were washed and then
permeabilized with 80 mg/ml digitonin for 10 min at room temperature
to release soluble cytosolic proteins. Sodium dodecyl sulfate (0.6%)
was then added to both infected and permeabilized cells to solubilize
cellular components. The amounts of radioactive proteins released by
the treatments were quantitated by liquid scintillation counting and are
reported as the percentage released compared to the total radioactivity
present (supernatants plus cells). The values shown represent
means 6 SEM of identical experiments performed in cultures estab-
lished from four corneal donors.
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cells (Roizman and Sears, 1996). Consequently, how is it
possible for infected HCEC to secrete newly formed virus
progeny without releasing IL-1a? Mature enveloped vi-
rus particles escape infected cells by being carried in
transport vesicles through the cells secretory pathway to
the plasma membrane, where they are actively secreted
(Banfield and Tufaro, 1990; Johnson and Spear, 1982).
Since IL-1a lacks a signal sequence and cannot interact
with intracellular secretory pathways (Bakouche et al.,
1987; Matushima et al., 1986; Stevenson et al., 1992), it
cannot be incorporated into vesicles carrying virions to
the cell surface. Therefore, it is likely that HSV-1-infected
HCEC release viral progeny without releasing IL-1a be-
cause HSV-1 escapes infected epithelial cells by exclu-
sive use of the exocytosis pathway.
Although HSV-1 infection of corneal epithelial cells
does not result in the detectable release of IL-1a in vitro,
one could envision that IL-1a could be released by these
cells following infection in vivo, for example, by the even-
tual disintegration of infected cells or by the course of
engulfment by phagocytic cells. However, it is known that
injured corneal epithelial cells are shed into the tear film,
where they are removed by the lavaging action of tears
(Davson, 1990). Thus, IL-1a leakage into corneal tissue in
vivo may also be minimal. This view is consistent with
the clinical observation that little or no inflammation
develops in corneas of individuals when HSV-1 infec-
tions are limited to epithelial layers of the cornea (Pep-
ose et al., 1996).
Following corneal infection, HSV-1 spreads into sen-
sory neurons which innervate the ocular surface (Fraser
et al., 1991). The release of intracellular stores of IL-1a is
believed to be an early warning signal by which epithelial
cells damaged by disease or injury alert host defenses of
microbial invasion (Dinarello, 1994a,b). The failure of
HSV-1 to induce significant IL-1a release from infected
HCEC may contribute to the pathogenesis of HSV-1 by
delaying induction of antiviral host responses, thereby
enhancing prospects for the virus to penetrate sensory
nerve endings and establish a latent infection in the
trigeminal ganglion. In addition to corneal epithelial
cells, HSV-1 also infects epithelial cells at other body
surfaces. It is not known if IL-1a is also retained in these
cells following HSV-1 infection.
MATERIALS AND METHODS
Cell culture and preparation of virus stocks
Human corneas were obtained from the National Re-
search Interchange (Philadelphia, PA). Epithelial cells
were isolated from the corneas and established in tissue
culture as previously described (Cubitt et al., 1993). Virus
stocks were prepared and titered on monolayers of hu-
man corneal fibroblasts by established procedures
(Oakes et al., 1993).
Kinetics of virus growth
Confluent cultures were infected with HSV-1 (RE) at a
m.o.i. of 3. At selected times postinfection, supernatants
were removed from the cultures and cells were then
dislodged from the plates with trypsin and sonicated to
release intracellular virus. The number of plaque-forming
units (PFU) in supernatants and cell lysates released
was determined by standard plaque assays on human
corneal fibroblasts (Oakes et al., 1993).
Assay of intracellular and extracellular IL-1a
Extracellular levels of IL-1a secreted from cell mono-
layers were determined by harvesting supernatants from
flasks at selected intervals postinfection. Intracellular
IL-1a levels were then determined by trypsinizing the cell
monolayers in 0.05% trypsin with EDTA (Gibco BRL,
Grand Island, NY). The cell membranes were then dis-
rupted by centrifuging cells at 14,000 g for 5 min at 4°C
and then sonicating the pelleted cells for 20 s in a Sonic
300 Dismembrator (Antek Systems Corp., Farmingdale,
NY). After resuspending the sonicated cells in 1 ml of
Keratinocyte Serum Free Medium (KSFM) (Gibco BRL),
both sonicated samples and supernatants were assayed
for IL-1a by an enzyme-linked immunosorbent assay
(ELISA) (R&D Systems Inc., Minneapolis, MN). The sen-
sitivity of the assay was 0.5 pg/ml. The significance of
differences between cytokine levels were evaluated by
using small sample paired t statistics.
Measurement of cell permeability in HSV-1-infected
cells
Epithelial cells were grown in KSFM containing half
the normal concentration of methionine and cysteine for
12 h. The medium was aspirated and the cells labeled
with methionine-free and cysteine-free DMEM contain-
ing labeled [35S]methionine and [35S]cysteine (Transla-
bel, ICN Pharmaceutical, Irvine, CA) for 3 h. The labeling
medium was removed from the flasks and the monolay-
ers were washed three times with PBS. The washed
monolayers were then either mock-infected or infected
with HSV-1. After virus absorption, the flasks were replen-
ished with KSFM and the monolayers incubated at 37°C.
For digitonin permeabilization, cells were rinsed three
times with PBS and then exposed to 80 mg/ml digitonin
for 10 min at room temperature. After removal of intact
cells by centrifugation, soluble proteins released into the
supernatant from HSV-1-infected cells, mock-infected
cells, or digitonin-permeabilized cells were quantitated
by scintillation counting in a Beckman LX500CE scintil-
lation counter (Beckman Inc., Fullerton, CA). The remain-
ing cell-associated proteins were then collected by
washing cell monolayers with 0.2 ml PBS followed by
treatment with 0.6% sodium duodecyl sulfate (SDS) in 10
mM EDTA for 2 min. Cell lysates were collected and
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centrifuged for 14,000 g for 5 min at 4°C. Aliquots were
counted in a liquid scintillation cocktail.
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